Try our Advanced Search for more refined results
Zydus Pharmaceuticals Inc.
- July 29, 2022 Hatch-Waxman Allowed Prevacid IP Suit, Takeda Tells 3rd Circ.
- July 11, 2022 Zydus Faces Xtandi Cancer Drug Patent Suit
- June 17, 2022 Generic Co. Asks Fed. Circ. To Undo Loss In Takeda IP Fight
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS